StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX)

StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research note released on Monday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of DURECT in a research note on Thursday, September 26th. Read Our Latest Stock Report […]

Leave a Reply

Your email address will not be published.

Previous post Victrex (LON:VCT) Hits New 12-Month Low – Time to Sell?
Next post Delcath Systems’ (DCTH) “Buy” Rating Reiterated at HC Wainwright